Behavioral pharmacology of melatonin

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 3, 1998, Pages 237-247

  Kulkarni, S K ^a   Shaji, A V ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; MELATONIN RECEPTOR;

BEHAVIOR; CENTRAL NERVOUS SYSTEM; HORMONE ACTION; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; PINEAL BODY; REVIEW;

ANIMALS; BEHAVIOR; CENTRAL NERVOUS SYSTEM; HUMANS; MELATONIN; PINEAL GLAND; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN;

EID: 0031802898     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Philo, R., Reiter, R.J. Characterization of pinealectomy induced convulsions in the Mongolian gerbil. Epilepsia 1978, 19: 485-92.
2. Kappers, T.A. Survey of the innervation of the epiphysis cerebri and the accessory pineal organs of vertebrates. In: The Structure and Function of the Epiphysis cerebri. Kappers, J.A., Schade, J.P. (Eds.). Elsevier: Amsterdam 1965, 87-151.
3. Ueck, M., Wake, E. The pinealocyte - a paraneuron. Prog Brain Res 1979, 52: 141-7.
4. Ralph, C.L. Evolution of pineal control of endocrine function in lower vertebrates. Am Zoologist 1983, 23: 597-605.
5. Papasozomenos, S.C. Glial fihrillary acidic (GFA) protein containing cells in the human pineal gland. J Neuro pathol Exp Neurol 1983, 42: 391-408.
6. Gauquelin, G., Geelers, G., Allevard Burgur Burn, A.M. Presence of neurophysins I and II in me human pineal gland: Comparison with content of neuron hypophyseal hormones. Peptides 1982, 3: 805-9.
7. Lowenthal, A., Flament-Dutand, J., Katcher, D. Glial cells identified by anti α-albumin (anti-GFA) in human pineal gland. J Neurochem 1982, 38: 863-5.
8. Samarasinghe, D.D., Petterberg, L.J., Zeagler, J.W. On the occurrence of a myeloid body in pinealocytes of the white footed mouse. Peromyscus leucopus. An electron microscopic study. Cell Tissue Res 1983, 228: 649-59.
9. Poeggler, B., Balzer, I., Hardeland, R. Lerchl, A. Pineal hormone melatonin oscillates also in the dinoflagellate, Gonyaulax polyhedra. Naturwissenchaften 1991, 78: 268-9.
10. Kumar, V. Melatonin: A master hormone and a candidate for universal panacea. Indian J Exp Biol 1996, 34: 391-402.
11. Arendt, J. The pineal gland: Basic physiology and clinical Implications. In: Endocrinology. DeGroot, L.J., Besier, M., Burger, H.G. et al. (Eds.). W.B. Saunders: Philadelphia 1995, 432-44.
12. Moore, R.Y., Paunier, L., Sizoneko, P.C. Effect of adrenergic stimulation and blockade of melatonin secretion in the humans. Prog Brain Res 1979, 52: 517-21.
13. Moore, R.Y., Klein, D.C. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyl transferase activity. Brain Res 1974, 71: 17-33.
14. Moore, R.Y., Klein, D.C. Neural control of pineal function in mammals and birds. J Neural Transm (Suppl.) 1978, 13: 47-51.
15. Buda, M., Klein, D.C. A suspension culture of pinealocytes. Regulation of N-acetyl transferase activity. Endocrinology 1978, 103: 1483-9.
16. Meijer, J.H. Integration of visual information by supachiasmatic nucleus. In: Suprachiasmatic Nucleus. Klein, D.C., Moore, R.Y., Reppert, S.M. (Eds.). Oxford University Press: Oxford 1991, 107.
17. Vakkuri, O., Leppaluoto, J., Kaupplia, A. Oral administration and distribution of melatonin in human serum saliva and urine. Life Sci 1985, 37: 489-95.
18. Kopin, J.I., Pare, C.M.B., Axelrod, J., Weissbach, H. The fate of melatonin in animals. J Biol Chem 1961, 236: 3072-5.
19. Ozaki, Y., Wurtman, R.J. Melatonin in pineal plasma and urine: 24 hour rhythmicity and effect otchlororomazine. Endocrinology 1976, 98: 1418-24.
20. Hirata, F., Hayaishi O., Tokuyama, T., Serioli, S. In vitro and in vivo formation of two metabolites of melatonin. J Biol Chem 1974, 249: 1611-6.
21. Rogawski, M.A., Roth, R.H., Aghajanian, G.K. Melatonin: Deacetylation to 5-methoxytryplamine by liver but not brain aryl acyl amidase. J Neurochem 1979, 32: 1219-26.
22. Morgan, P.J., Williams, L.M. Central melatonin receptors: Implications for a mode of action. Experientia 1989, 45: 955-65.
23. Dubocovich, M.L. Melatonin receptors: Are there multiple subtypes? Trends Pharmacol Sci 1995, 16: 50-6.
24. Ebisawa, T., Suresh, K., Lerner, M.R., Reppert, S.M. Expression of cloning of a high affinity melatonin receptor from Xenopus dermal melanophores. Proc Nat Acad Sci USA 1994, 91: 6133-7.
25. Reppert, S.M., Weaver D.R., Godson, C. Melatonin receptors step into the light: Cloning and classification of subtypes. Trends Pharmacol Sci 1996, 17: 100-2.
26. Sherin, J.E., Shiromani, P.J., McCartey, R.W., Saper, C.B. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271: 216-9.
27. Dubocovich, M.L. Melatonin is a potent modulator of dopamine release in the retina. Nature 1983, 306: 782-5.
28. Krause, D.N., Dubocovich, M.L. Regulatory sites in the melatonin system of mammals. Trends Neuro Sci 1993, 13: 464-70.
29. Vanecek, K.J., Klein, D.C. In: Advances in Pineal Research. Moller. M., Pevet, P. (Eds.). John Libbey: 1994, 363-70.
30. Krause, D.N., Dubocovich, M.L. Melatonin receptors. Anna Rev Pharmacol Toxicol 1991, 31: 549-68.
31. Cagnacci, A., Elliot, J.A., Yen, S.S.C. Melatonin: A major regulator of the circadian rhythm of core temperature in humans. J Clin Endocri Metab 1992, 75: 447-52.
32. Marczynski, T.J., Yamaguchi, N., Ling, G.M., Gordzinka, L. Sleep induced by the administration of melatonin to the hypothalamus in unrestrained cats. Experientia 1964, 20: 435-7.
33. Barchas, J., Da Costa, F., Spector, S. Acute pharmacology of melatonin. Nature 1967, 919-20.
34. Sugden, D. Psychopharmacological effects of melatonin in mouse and rat. J Pharm Exp Ther 1983, 227: 587-91.
35. Reiter, R.J., Blask, D.E., Johnson, L.Y., Rudern, P.K., Vanghan, M.K., Waring, P.J. Melatonin inhibition of reproduction in the male hamster: Its dependency on time of day of administration and on intact and sympathetically innervated pineal gland. Neuroendocrinology 1976, 22: 107-16.
36. Zhdanova, I.V., Wurtman, R.J., Lynch, H.J. et al. Sleep inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Therap 1995, 57: 552-8.
37. Lerner, A.B., Nordlund, J.J. Comment: Administration of melatonin to human subjects. In: Frontiers of Pineal Physiology M.D. Altschule (Ed.). MIT Press: Cambridge 1975, 42-3.
38. Lehmann, E.D., Cockerell, O.C., Rudge, P. Somnolence associated with melatonin deficiency after pinealectomy. Lancet 1996, 347: 323.
39. Hartley, R., Padwick, D., Smith, J.A. The inhibition of pineal hydroxyindole O-methyl transferase by haloperidol and fluphenazine. J Pharm Pharmacol 1972, 24: 100-3.
40. Naylor, R.J., Olley, J.E. The distribution of haloperidol in rat brain. Br J Pharmacol 1959, 36: 208-9.
41. Udenfriend, J., Witkop, B., Redfield, B.G., Weissbach, H. Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds. Biochem Pharmacol 1958, 1: 160-5.
42. Mclssac, W.M. A biochemical concept of mental disease. Post Grad Med 1961, 30: 111-8.
43. Anton Tay, F., Diaz, J.L., Fernandez-Guerdick, M. On the effects of melatonin upon human brain: Its possible therapeutic implications. Life Sci 1971, 10: 841-50.
44. Wendel, O.T., Waterbury, L.D., Pearce, L.A. Increase in monoamine concentrations in rat brain following melatonin administration. Experientia 1974, 30: 1167-8.
45. Birau, N., Alexander, D., Bertholdt, S., Meyer, C. Low nocturnal melatonin serum concentrations in anorexia nervosa - further evidence for body weight influence. IRCS Med Sci Psychol Psychiatry 1984, 12: 477.
46. Ralph, M.R. Suprachiasmatic nucleus transplant studies using the tau mutation in golden hamsters. In: Suprachiasmatic Nucleus: The Mind's Clock. Klein, D.C., Moore, R.Y., Reppert, S.M. (Eds.). Oxford: New York 1991, 341-8.
47. Gwinner, E. In: Evolution of Circadian Clocks. Hiroshinge, T., Honma, K. (Eds.). Hokkaido University Press: Sappora 1994, 127.
48. Badia, P., Myers, B., Murphy, P. In: Melatonin: Biosynthesis Physiological Effects and Clinical Applications. Reiter, R.J., Yu, H.S. (Eds.). CRC Press: Boca Raton 1992, 349.
49. Redman, J.R., Armstrong, S.M. Re-entrainment of rat circadian rhythms: Effects of melatonin. J Pineal Res 1988, 5(2): 503-15.
50. Sack, R.L., Lewy, A.J., Hughes, R.J., McArthur, A.J., Blood, M.L. Melatonin as a chronobiolic drug. Drug News Perspect 1996, 9(6): 325-32.
51. Demaine, C., Kann, H.C. Effect of pinealectomy on the electrical responses of hypothalamic neurones to the application of melatonin. In: Advances in the Biosciences Melatonin: Current Status and Perspectives. Vol. 29. Birau, N., Schloot, W. (Eds.). Oxford: Pergamon Press 1980, 123-8.
52. Fariello, R.G., Bubenik, G.A., Brown, G.M., Girota, L.J. Epileptogenic action of intraventricularly injected antimelatonin antibody. Neurology 1977, 27: 567-70.
53. Parfitt, A., Klein, D. Increase caused by desmethyl imipramine in the production of t3HJ melatonin by isolated pineal glands. Biochem Pharmacol 1977, 26: 904-5.
54. Friedman, E., Yocca, F.D., Cooper, T.B. Antidepressant drugs with varying pharmacological profiles alter rat pineal β-adrenergic mediated function. J Pharm Exp Ther 1984, 228: 545-50.
55. Yocca, F.D., Depaul Lynch, V., Friedman, E. Effect of chronic lithium treatment on rat pineal rhythms: N-acetyl transferase. N-acetyl serotonin and melatonin. J Pharmacol Exp Ther 1983, 226: 733-7.
56. Grasby, P.M., Cowen, P.J. Clonidine fails to suppress plasma melatonin in man. Br J Pharmacol 1987; 36.
57. Mogilnicka, E., Dubocovich, M.L. Effect of the melatonin receptor antagonist luzindole (N-0774) in the mouse behavioural despair test. Soc Neurosci Abstr 1987, 13: 1039.
58. Beck Friis, J., Ljunggren, J.G., Thoren, M., Von Rosen, D., Kjellman, B.F., Wetterberg, L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humuns with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 1985, 10: 173-86.
59. Brown, R., Kocsis, J.H., Caroff, F., Amsterdam, J., Winokur, A., Stokes, P.E., Frazer, A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiat 1985, 142: 811-6.
60. Kennedy, S.H., Tighe, S., Mcvey, G., Brown, G.M. Melatonin and cortisol "switches" during mania, depression and euthymia in a drug free bipolar patient. J Nerv Ment Dis 1989, 177: 300-3.
61. Moore-Ede, M.C., Czeisler, C.A., Richardson, G.S. Circadian timekeeping in health and disease. Part 2 - Clinical implications of circadian rhythmicity. New Engl J Med 1983, 309: 530-6.
62. Wehr, T.A., Wirz Justice, A., Goodwin, F., Duncan, W., Gillin, J.C. Phase advance of the circadian sleep wake cycle as an antidepressant. Science 1979, 206: 710-3.
63. Pierpaoli, W., Yi, C.X. The involvement of pineal gland and melatonin in immunity and aging. I. Thymus-Mediated, immunoreconstituting and antiviral activity of thyrotropin - releasing hormone. J Neuroimmunol 1990, 27: 99-110.
64. Pierpaoli, W., Dallara, A., Pedrinis, E., Regelson, W. The effects of melatonin and pineal grafting on the survival of older mice. Ann NY Aca Sci 1991, 621: 291-313.
65. Tan, D.X., Chen, L.D., Poeggler, B., Manchester, L.C., Reiter, R.J., Saarela, S. Melatonin, a potent endogenous hydroxyl radical scavenger. Endocri J 1993, 1: 57-60.
66. Wetterburg, L. Melatonin in human physiological and clinical studies. J Neural Transms 1978 (Suppl.), 13: 289-310.
67. Miline, R. The role of pineal gland in stress, J Neural Transms 1980, 47: 191-220.
68. Carr, D.B., Reppert, S.M., Bublen, B. Plasma melatonin increases during exercise in women. J Clin Endocrin Metab 1981, 53: 224-5.
69. Lowenstein, P.R., Pereyra, E.N., Solveyra, C.G., Cardinali, D.P. Effect of naloxone on the nocturnal rise of rat pineal melatonin content. Eur J Pharmacol 1984, 8: 261-4.
70. Kavalsiers, M., Hirst, M., Teskey, G.C. Aging, opioid analgesia and the pineal gland. Life Sci 1983, 32: 2279-87.